Lawrence Feldman, MD
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Pembrolizumab + Imprime PGG for Metastatic Non-small Cell Lung Cancer After Progression on First-Line Therapy: Big Ten Cancer Research Consortium BTCRC-LUN15-017 (NCT03003468) | Lawrence Feldman, MD | 2017-07-11 |
Track Lawrence Feldman, MD automatically
Every clearance here is in the API, with alerts when new ones post.